<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246620/" ref="ordinalpos=1794&amp;ncbi_uid=6891250&amp;link_uid=PMC4246620" image-link="/pmc/articles/PMC4246620/figure/f1-ol-09-01-0235/" class="imagepopup">Figure 1.  From: The expression of Wnt-1 inducible <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> protein-2 in astrocytoma: Correlation between pathological grade and clinical outcome. </a></div><br /><div class="p4l_captionBody">Reverse transcription-polymerase chain reaction analysis of WISP-2 expression levels in normal brain tissues and human astrocytomas of different grades. GAPDH was used as an internal standard. Representative images of electrophoresis of WISP-2 mRNA. A one-way analysis of variance was used for tests of significance: P&lt;0.01, significant difference from the normal control. WISP-2, Wnt-1 inducible signaling pathway protein-2; N, normal brain tissue; Iâ€“IV, astrocytoma grades.</div></div>